Nolet Chris (CIK 1782814) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-02-06). Recent activity: Sell RVNC (28,606 shares), Sell RVNC (15,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-02-06 | Revance Therapeutics, Inc. (RVNC) | Director | Sell | 28,606 | $104,412 |
| 2025-02-06 | Revance Therapeutics, Inc. (RVNC) | Director | Sell | 15,000 | $0 |
Source: SEC Form 4 filings · as of 2025-02-06